We have located links that may give you full text access.
Mechanical Thrombectomy Outcome Predictors in Stroke Patients with M2 Occlusion: A Single-Center Retrospective Study.
World Neurosurgery 2019 March 12
BACKGROUND: Mechanical thrombectomy (MT) has demonstrated benefit in patients with acute ischemic stroke due to proximal large vessel occlusion. However, it is unclear, whether these results can be extrapolated to patients with an occlusion of the second segment (M2) of the middle cerebral artery (MCA).
OBJECTIVE: To study outcomes in patients with M2 occlusion treated with MT and to better understand clinical predictors of these outcomes.
METHODS: We performed a single-center retrospective analysis of consecutive patients with acute MCA M2 segment occlusion who underwent stent retriever MT. We correlated clinical and radiographic outcomes with demographic, clinical, and technical characteristics.
RESULTS: Thirty-seven patients were included in the analysis (median admission National Institutes of Health Stroke Scale [NIHSS] score, 15 [12-19], mean age 74 [67-80] years, 48.6% women). Good clinical outcome at 3 months (modified Rankin scale [mRS] ≤ 2) was achieved in 48.6% of patients. Baseline NIHSS was a predictor of clinical outcomes, based on mRS distribution at 3 months after MT (P = .032, odds ratio [OR] 1.81, 95% confidence interval [CI] 1.05-3.10).
CONCLUSION: The results of our single-institution experience suggest that MT-based endovascular therapy for M2 occlusions is safe and effective. Baseline NIHSS was a predictor of outcomes in patients treated with MT for M2 segment occlusion of the MCA.
OBJECTIVE: To study outcomes in patients with M2 occlusion treated with MT and to better understand clinical predictors of these outcomes.
METHODS: We performed a single-center retrospective analysis of consecutive patients with acute MCA M2 segment occlusion who underwent stent retriever MT. We correlated clinical and radiographic outcomes with demographic, clinical, and technical characteristics.
RESULTS: Thirty-seven patients were included in the analysis (median admission National Institutes of Health Stroke Scale [NIHSS] score, 15 [12-19], mean age 74 [67-80] years, 48.6% women). Good clinical outcome at 3 months (modified Rankin scale [mRS] ≤ 2) was achieved in 48.6% of patients. Baseline NIHSS was a predictor of clinical outcomes, based on mRS distribution at 3 months after MT (P = .032, odds ratio [OR] 1.81, 95% confidence interval [CI] 1.05-3.10).
CONCLUSION: The results of our single-institution experience suggest that MT-based endovascular therapy for M2 occlusions is safe and effective. Baseline NIHSS was a predictor of outcomes in patients treated with MT for M2 segment occlusion of the MCA.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app